Zevra Therapeutics, Inc. Share Price

Zevra Therapeutics, Inc. Share Price

NASDAQ: ZVRA | Small Cap
$10.21
-$0.14 (-1.4%) Last updated on 30 Oct, 2026 | 23:45 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Zevra Therapeutics, Inc. Stock Performance

Open
$10.44
Prev. Close
$10.36
Circuit Range
N/A
Day Range
$10.15 - $10.44
Year Range
$8.02 - $15.04
Volume
10,450
Average Traded
$10.25

Zevra Therapeutics, Inc. Share Price Today

As of 30 October 2026, Zevra Therapeutics, Inc.'s share price is $10.21. The stock opened at $10.44, compared to its previous close of $10.36. During today's trading session, Zevra Therapeutics, Inc.'s share price traded between $10.15 and $10.44, with an average price of $10.29. Over the past 52 weeks, the stock has recorded a high of $15.04 and a low of $8.02. In terms of performance, Zevra Therapeutics, Inc.'s share price has risen by 0.39% over the last six months and is up 0.39% on a year-on-year basis.

Zevra Therapeutics, Inc. Share Price Chart

Line chart of the Zevra Therapeutics, Inc. price trend over the selected period. The price fell overall, ranging from 10.15 to 10.51, ending at 10.21.
$10.15$10.44
L
Show Current Price
H

Zevra Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$564.73M
PE Ratio (TTM)
10.62
Dividend Yield
0.00%
EPS (TTM)
$0.98
Revenue (TTM)
$106.47B
Return On Equity (TTM)
26.60%
Profit Margin
78.17%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
1653.70%

Zevra Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$26.06$34.13$36.22$39.66
Net Profit-$0.54$12.17$37.89$8.39
Net Profit Margin-2.07%35.66%104.61%21.15%
Income ChangeN/A2353.70%211.34%-77.86%

Zevra Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$27.46$23.61$106.47
Net Profit-$46.05-$105.51$83.23
Net Profit Margin-167.70%-446.89%78.17%
Income ChangeN/A-129.12%178.88%

About Zevra Therapeutics, Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Zevra Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$10.82
$10.15
-7.43%
Sep 2026
$11.73
$10.96
-7.39%
Aug 2026
$9.54
$11.84
+24.37%
Jul 2026
$14.44
$9.52
-33.57%
Jun 2026
$11.51
$14.33
+23.32%
May 2026
$10.15
$11.62
+14.26%
Apr 2026
$9.43
$10.17
+9.00%
Mar 2026
$8.91
$9.33
+4.36%
Feb 2026
$8.91
$8.94
-0.78%
Jan 2026
$8.90
$9.01
+0.56%
Dec 2025
$8.38
$8.96
+6.29%
Nov 2025
$9.99
$8.43
-17.11%

ZVRA Share Price FAQs